Especially in the context of patients with acromegaly, in whom we observed a stronger difference in the neuroendocrine component of the AL index relative to the control group, a chronic excess of growth hormone and IGF-I promotes chronic inflammation and metabolic dysfunction. This evidence concerns the gene IGF1 and acromegaly.